
Advantages of a National Tender System for Clotting Factor Concentrates – Arabic
Also Available In: Japanese A national tender system is a cost-effective system for the purchase of products or services, such
Year: 2021
Language: Arabic
This resource is also available in: الإنجليزية الفرنسية الروسية الأسبانية
Format: Video
How is the pandemic impacting global healthcare systems around the world? What will the “new normal” be? In this opening session from the Global Policy and Access Summit, Cesar Garrido (WFH President) and Glenn Pierce, MD (WFH VP Medical) will address the effects of the pandemic on WFH’s vision of Treatment for All, as well as highlight the current state of access to treatment and care. Keynote speaker Mariângela Simão, MD (WHO) will also discuss the impact of the Universal Health Coverage priorities and Sustainable Development Goals on access to care for people with inherited bleeding disorders. Join us to find out what role must patient organizations, healthcare professionals and governments play in improving access to care.
This WFH session was originally presented in English.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

Also Available In: Japanese A national tender system is a cost-effective system for the purchase of products or services, such

Also Available In: Japanese Patient registries are crucial for monitoring trends in health, allocating resources, organizing and tracking distribution of

Having a national patient registry means being able to answer fundamental questions about the hemophilia population within a given country.